Atlas Trials

Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.

Clinical trial NCT06846905 · RECRUITING

Trial details

NCT number
NCT06846905
Sponsor
University Hospital, Toulouse
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma in Relapse
Start date
2025-01-20
Primary completion
2026-09-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.